The two are hardly comparable though. IMU is/was years ahead of...

The two are hardly comparable though. IMU is/was years ahead of RAC in the clinic. They had multiple trials, dosing patients, and had a MC over $3b at one stage... Large instos come in, trials progress, human resources are increased, spending increases, dilution happens, etc, etc... unfortunately for IMU the SP has dropped, but expenses are still high.

With any luck RAC will finally dose a patient this year (I've been patiently waiting for 5 years - I even opted for RAC over IMU in 2019), our SP will rocket, and we will hopefully be in the position of a $3b MC, instos wanting to come on board, multiple trials commenced, human resources increased, and building our value...

We can't really compare the two when RAC is just at the starting line, and IMU has hit a few hurdles half way along.

*full disclosure: I was, and still am, 100% RAC rusted-on